Sarepta Therapeutics (SRPT) PT Lowered to $160 at Needham & Company
Needham & Company analyst Gil ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)